Merus N.V. Competitors
Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
---|---|---|---|---|---|
![]() ACRV
Acrivon Therapeutics, Inc. Common Stock |
$6.79 | $223.86 M | -2.51 | 58 | $0 |
![]() ADAG
Adagene Inc. |
$1.98 | $131.46 M | -6.77 | 174 | $18.11 M |
![]() ANAB
AnaptysBio, Inc. |
$15.30 | $640.07 M | -3.82 | 136 | $91.28 M |
![]() ANEB
Anebulo Pharmaceuticals, Inc. |
$1.62 | $56.28 M | -5.86 | 2 | $0 |
![]() CERE
Cerevel Therapeutics Holdings, Inc. |
$44.96 | $7.29 B | -14.66 | 355 | $0 |
![]() CRNX
Crinetics Pharmaceuticals, Inc. |
$50.49 | $3.53 B | -11.86 | 437 | $1.04 M |
![]() INBX
Inhibrx Biosciences, Inc. |
$16.52 | $241.02 M | -1.44 | 166 | $1.80 M |
![]() KRON
Kronos Bio, Inc. |
$0.97 | $44.62 M | -0.37 | 62 | $6.29 M |
![]() KURA
Kura Oncology, Inc. |
$8.51 | $1.66 B | -10.03 | 192 | $53.88 M |
![]() LRMR
Larimar Therapeutics, Inc. |
$3.96 | $611.84 M | -9.99 | 42 | $0 |
![]() LYEL
Lyell Immunopharma, Inc. |
$0.68 | $619.50 M | -2.7 | 224 | $61,000 |
![]() MLYS
Mineralys Therapeutics, Inc. |
$13.05 | $652.38 M | -6.03 | 51 | $0 |
![]() PCVX
Vaxcyte, Inc. |
$85.99 | $7.72 B | -16.54 | 414 | $0 |
![]() PTGX
Protagonist Therapeutics, Inc. |
$38.09 | $2.04 B | 13.7 | 126 | $434.43 M |
![]() REPL
Replimune Group, Inc. |
$12.02 | $485.18 M | -2.44 | 331 | $0 |
![]() SNDX
Syndax Pharmaceuticals, Inc. |
$13.69 | $1.66 B | -6.02 | 270 | $23.68 M |
![]() STRO
Sutro Biopharma, Inc. |
$2.04 | $303.46 M | -1.97 | 306 | $153.73 M |